PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11093763-3	2000	N-(3-Trifluoromethylphenyl)piperazine, a 5-HT(1B) receptor agonist, potently inhibited 5-HT(1A) receptor-mediated slow inhibitory postsynaptic potentials (IPSPs) in the dorsal raphe of wild-type but not knockout mice.	1-(3-trifluoromethylphenyl)piperazine	0-37	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	41-58	
9291149-0	1997	TFMPP, a 5HT1B receptor agonist, inhibits light-induced phase shifts of the circadian activity rhythm and c-Fos expression in the mouse suprachiasmatic nucleus.	1-(3-trifluoromethylphenyl)piperazine	0-5	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	9-23	
10234032-5	1999	1-[3-(Trifluoromethyl)phenyl]-piperazine HCl (TFMPP), a 5-HT1B receptor agonist, reduced in a dose-related manner the amplitude of glutamatergic EPSCs evoked by stimulating selectively the optic nerve.	1-(3-trifluoromethylphenyl)piperazine	46-51	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	56-71	
9291149-4	1997	We tested this hypothesis using the 5HT1B receptor agonist, 1-[3-(trifluoromethyl)phenyl]-piperazine (TFMPP).	1-(3-trifluoromethylphenyl)piperazine	60-100	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	36-50	
9291149-4	1997	We tested this hypothesis using the 5HT1B receptor agonist, 1-[3-(trifluoromethyl)phenyl]-piperazine (TFMPP).	1-(3-trifluoromethylphenyl)piperazine	102-107	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	36-50	
1628159-13	1992	In the social behaviour deficit test, anpirtoline and trifluoromethylphenyl-piperazine were effective in reversing the isolation-induced impairments in mice, an effect shown only by compounds with agonist properties at the 5-HT1B receptor.	1-(3-trifluoromethylphenyl)piperazine	54-86	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	223-238	
9169822-4	1997	In addition, topical administration of the 5-HT1B agonist M-trifluoromethylphenylpiperazine (2 x 10(-6) to 2 x 10(-4) M) produced opposite responses, i.e., dose-dependent vasodilation in TIA and control arterioles, and dose-dependent constriction in TFA.	1-(3-trifluoromethylphenyl)piperazine	58-91	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	43-49	
7972302-2	1994	The behavioral model used (increase in escape attempts of isolated mice) has been previously shown to be exclusively responsive to 5-HT1B agonists such as 1-3-(trifluoromethyl) phenylpiperazine (TFMPP).	1-(3-trifluoromethylphenyl)piperazine	155-193	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	131-137	
7972302-2	1994	The behavioral model used (increase in escape attempts of isolated mice) has been previously shown to be exclusively responsive to 5-HT1B agonists such as 1-3-(trifluoromethyl) phenylpiperazine (TFMPP).	1-(3-trifluoromethylphenyl)piperazine	195-200	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	131-137	
1971720-1	1990	Seven days of isolation induce in mice a social behavioral deficit (decrease in escape attempts) reversed by TFMPP acting through activation of 5-HT1B receptors.	1-(3-trifluoromethylphenyl)piperazine	109-114	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	144-150	
1833660-1	1991	In mice, isolation-induced social behavioural deficits are attenuated by stimulants of 5-HT1B receptors, such as TFMPP or CGS 120 66B.	1-(3-trifluoromethylphenyl)piperazine	113-118	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	87-93	
1975081-6	1990	The preferential 5-HT1B agents TFMPP and mCPP exhibited a profile similar to PTZ.	1-(3-trifluoromethylphenyl)piperazine	31-36	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	17-23	
1975081-8	1990	The decreased entries and time spent on the open arm of the maze following TFMPP or mCPP administration was possibly mediated by an antagonistic action at 5-HT1B receptors, since this effect was reversed by the selective 5-HT1B agonist CGS 12066B.	1-(3-trifluoromethylphenyl)piperazine	75-80	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	155-161	
1975081-8	1990	The decreased entries and time spent on the open arm of the maze following TFMPP or mCPP administration was possibly mediated by an antagonistic action at 5-HT1B receptors, since this effect was reversed by the selective 5-HT1B agonist CGS 12066B.	1-(3-trifluoromethylphenyl)piperazine	75-80	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	221-227	
2969949-0	1988	Hypothermia induced by m-trifluoromethylphenylpiperazine or m-chlorophenylpiperazine: an effect mediated by 5-HT1B receptors?	1-(3-trifluoromethylphenyl)piperazine	23-56	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	108-114	
3252258-1	1988	The effect of TFMPP, an agonist of the 5-HT1b receptors, was studied in mice on several psychopharmacological parameters.	1-(3-trifluoromethylphenyl)piperazine	14-19	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	39-45	
3252258-6	1988	It is concluded that TFMPP seems to possess psychotropic activity resembling only in part that of imipramine-like drugs and that these actions may be mediated through 5-HT1b receptors.	1-(3-trifluoromethylphenyl)piperazine	21-26	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	167-173	
2969949-6	1988	The obtained results indicate that the TFMPP- and m-CPP-induced hypothermias in mice are mediated by 5-HT1B.	1-(3-trifluoromethylphenyl)piperazine	39-44	5-hydroxytryptamine (serotonin) receptor 1B	Mus musculus	101-107